Subtype
Male Reproductive System Neoplasm
CI-CAN-00001107Explore in graph →
Non-malignant1,533 active trials27 approved drugs58 evidence items
- NCIt
- C3054
Loading cancer entity…
Loading cancer entity…
Subtype
CI-CAN-00001107Explore in graph →
Clinical trials
6,899 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00332280 | Study to Evaluate the Clinical Benefit Response in Cancer Patients With Advanced Disease With AMT2003 Versus Placebo | terminated | Phase 2 / Phase 3 | 67 | Auron Healthcare GmbHINDUSTRY | 2 | Mar 20, 2013 | clinicaltrials |
| NCT00003819 | Vaccine Therapy Plus QS21 in Treating Patients With Progressive Prostate Cancer | completed | Phase 1 | 21 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Mar 19, 2013 | clinicaltrials |
| NCT00016146 | Vaccine Therapy Plus Biological Therapy in Treating Patients With Prostate Cancer | completed | Phase 1 | 34 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Mar 19, 2013 | clinicaltrials |
| NCT01344564 | Initiation of Androgen Deprivation Therapy for Prostate Cancer Using Degarelix Followed by Leuprolide | completed | N/A | 50 | Urology of VirginiaOTHER | 1 | Mar 18, 2013 | clinicaltrials |
| NCT01813097 | Combination Iodine 125 Seed Implants and LHRH Agonists for Locally Advanced (Stage T3) Prostate Cancer | completed | — | 60 | Chinese PLA General HospitalOTHER | 0 | Mar 18, 2013 | clinicaltrials |
| NCT00314782 | Phase I Study of ZD4054 (Zibotentan) and Docetaxel in Patients With Metastatic HRPC | completed | Phase 1 | 44 | AstraZenecaINDUSTRY | 3 | Mar 12, 2013 | clinicaltrials |
| NCT00244998 | Fulvestrant in Treating Patients With Advanced Prostate Cancer | completed | Phase 2 | 20 | Roswell Park Cancer InstituteOTHER | 1 | Mar 8, 2013 | clinicaltrials |
| NCT00676650 | Sunitinib Plus Prednisone In Patients With Metastatic Castration-Resistant Prostate Cancer After Failure Of Docetaxel Chemotherapy(SUN 1120) | terminated | Phase 3 | 873 | PfizerINDUSTRY | 22 | Mar 8, 2013 | clinicaltrials |
| NCT00003173 | High-Dose Thiotepa Plus Peripheral Stem Cell Transplantation in Treating Patients With Refractory Solid Tumors | completed | Phase 2 | 36 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Mar 7, 2013 | clinicaltrials |
| NCT01478308 | Metformin With Standard Taxotere and Prednisone in the Treatment of Castration Resistant Prostate Cancer | withdrawn | Phase 2 | 0 | New Mexico Cancer Research AllianceOTHER | 0 | Mar 6, 2013 | clinicaltrials |
| NCT00002848 | Group Therapy Compared With Educational Materials in Patients With Prostate Cancer | completed | N/A | 480 | Gary MorrowOTHER | 1 | Mar 5, 2013 | clinicaltrials |
| NCT00213694 | PROSTACOX : Metastatic Prostate Chemotherapy | completed | — | 52 | University Hospital, RouenOTHER | 1 | Mar 5, 2013 | clinicaltrials |
| NCT00589966 | Coping in African American Prostate Cancer Survivors(CAAPS) | completed | N/A | 62 | Duke UniversityOTHER | 1 | Mar 1, 2013 | clinicaltrials |
| NCT00002723 | Low, Intermediate, or High Dose Suramin in Treating Patients With Hormone-Refractory Prostate Cancer | completed | Phase 3 | 390 | National Cancer Institute (NCI)NIH | 2 | Feb 28, 2013 | clinicaltrials |
| NCT00004074 | Interleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of HER2/Neu | completed | Phase 1 | 15 | National Cancer Institute (NCI)NIH | 1 | Feb 28, 2013 | clinicaltrials |
| NCT00103337 | Cilengitide in Treating Patients With Metastatic Prostate Cancer | completed | Phase 2 | 106 | National Cancer Institute (NCI)NIH | 1 | Feb 28, 2013 | clinicaltrials |
| NCT01522118 | MR-guided Focused Ultrasound Treatment of Prostate Cancer: Focal Therapy for Locally Non-Advanced Disease | completed | Phase 1 | 12 | University of Roma La SapienzaOTHER | 1 | Feb 26, 2013 | clinicaltrials |
| NCT01672411 | Predictive Value of Prostate-specific Antigen Isoform p2psa and Its Derivates in the Diagnosis of Prostate Cancer | completed | — | 250 | University Of PerugiaOTHER | 1 | Feb 26, 2013 | clinicaltrials |
| NCT00869739 | Helping African American Prostate Cancer Survivors and Their Partners Cope With Challenges After Surgery for Prostate Cancer | completed | N/A | 112 | East Carolina UniversityOTHER | 1 | Feb 25, 2013 | clinicaltrials |
| NCT00004604 | Biological Therapy in Treating Patients With Metastatic Cancer | completed | Phase 1 | 24 | Duke UniversityOTHER | 1 | Feb 22, 2013 | clinicaltrials |
| NCT00757692 | Efficacy and Safety Study of Vandetanib (ZD 6474) in Combination With Bicalutamide Versus Bicalutamide Alone in Patients With Chemotherapy Naive Hormone Refractory Prostate Cancer. | completed | Phase 2 | 74 | British Columbia Cancer AgencyOTHER | 1 | Feb 20, 2013 | clinicaltrials |
| NCT00882232 | Cross-linked Hyaluronan Gel Reduces Rectal Toxicity Due to Radiation Therapy for Prostate Cancer | completed | Phase 1 | 10 | Cancer Center of IrvineOTHER | 1 | Feb 15, 2013 | clinicaltrials |
| NCT01379742 | Comparison of Between ThinSeed™ and OncoSeed™ for Permanent Prostate Brachytherapy | unknown | Phase 4 | 240 | Prostate Cancer Foundation of ChicagoOTHER | 1 | Feb 13, 2013 | clinicaltrials |
| NCT01379872 | Assessment of New Radiation Oncology Technologies and Treatments(ANROTAT) | completed | — | 138 | Trans Tasman Radiation Oncology GroupOTHER | 1 | Feb 13, 2013 | clinicaltrials |
| NCT01071915 | Efficacy and Safety of Degarelix One Month Dosing Regimen in Korean Patients With Prostate Cancer | completed | Phase 3 | 157 | Ferring PharmaceuticalsINDUSTRY | 1 | Feb 12, 2013 | clinicaltrials |
| NCT01174017 | Ability of a New Design of Iodine 125 Seed to Maintain Intended Position When Implanted in the Prostate(FAST) | completed | Phase 3 | 41 | British Columbia Cancer AgencyOTHER | 1 | Feb 12, 2013 | clinicaltrials |
| NCT00003256 | Flavopiridol in Treating Patients With Recurrent Prostate Cancer | completed | Phase 2 | 40 | National Cancer Institute (NCI)NIH | 1 | Feb 11, 2013 | clinicaltrials |
| NCT00004029 | Vaccine Therapy in Treating Patients With Metastatic Prostate Cancer | completed | Phase 1 | 46 | National Cancer Institute (NCI)NIH | 1 | Feb 11, 2013 | clinicaltrials |
| NCT00027599 | APC8015 and Bevacizumab in Treating Patients With Prostate Cancer | completed | Phase 2 | 25 | National Cancer Institute (NCI)NIH | 1 | Feb 11, 2013 | clinicaltrials |
| NCT00394511 | Radiation Therapy After Prostatectomy in Treating Patients With Stage III Prostate Cancer | completed | Phase 3 | 408 | National Cancer Institute (NCI)NIH | 0 | Feb 11, 2013 | clinicaltrials |
| NCT00978991 | Duke Urology Database and Specimen Bank | completed | — | 87,820 | Duke UniversityOTHER | 1 | Feb 8, 2013 | clinicaltrials |
| NCT00962494 | Cancer: Thriving and Surviving Online Workshop and Study for Cancer Survivors | completed | Phase 2 | 585 | Stanford UniversityOTHER | 2 | Feb 7, 2013 | clinicaltrials |
| NCT00030901 | S9917, Selenium in Preventing Cancer in Patients With Neoplasia of the Prostate | completed | Phase 3 | 619 | SWOG Cancer Research NetworkNETWORK | 0 | Feb 6, 2013 | clinicaltrials |
| NCT00265070 | Trial of Iressa in Prostate Cancer Patients | completed | Phase 2 | 80 | AstraZenecaINDUSTRY | 1 | Feb 5, 2013 | clinicaltrials |
| NCT00433446 | S0354, Anti-IL-6 Chimeric Monoclonal Antibody in Patients With Metastatic Prostate Cancer That Did Not Respond to Hormone Therapy | completed | Phase 2 | 62 | SWOG Cancer Research NetworkNETWORK | 1 | Feb 5, 2013 | clinicaltrials |
| NCT00040755 | BMS-275291 in Treating Patients With Prostate Cancer That Has Not Responded to Hormone Therapy | completed | Phase 2 | 68 | National Cancer Institute (NCI)NIH | 1 | Feb 1, 2013 | clinicaltrials |
| NCT00559481 | Ketoconazole, Dexamethasone, and Hydrocortisone in Treating Patients With Prostate Cancer That Did Not Respond to Androgen-Deprivation Therapy | withdrawn | N/A | 0 | Roswell Park Cancer InstituteOTHER | 0 | Feb 1, 2013 | clinicaltrials |
| NCT00004929 | Vaccine Therapy Plus QS21 in Treating Patients With Progressive Prostate Cancer | completed | Phase 1 | 15 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jan 31, 2013 | clinicaltrials |
| NCT00005632 | Vaccine Therapy Plus QS21 in Treating Patients With Prostate Cancer | completed | Phase 1 | 27 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jan 31, 2013 | clinicaltrials |
| NCT00276549 | Gemcitabine and Docetaxel in Treating Patients With Metastatic Prostate Cancer | completed | Phase 2 | 35 | Case Comprehensive Cancer CenterOTHER | 1 | Jan 31, 2013 | clinicaltrials |
| NCT00688532 | Study of Coronary Heart Disease (CHD) & Heart Failure (HF) Risk in Prostate Cancer Patients, Taking Casodex or Not | completed | — | 5,103 | AstraZenecaINDUSTRY | 0 | Jan 31, 2013 | clinicaltrials |
| NCT00939510 | Lenalidomide and GM-CSF in Treating Patients With Prostate Cancer | completed | Phase 1 / Phase 2 | 32 | Robert Dreicer MDOTHER | 1 | Jan 31, 2013 | clinicaltrials |
| NCT00383487 | A Phase II Trial of Calcitriol and Naproxen in Patients With Recurrent Prostate Cancer | terminated | Phase 2 | 20 | Stanford UniversityOTHER | 1 | Jan 28, 2013 | clinicaltrials |
| NCT00003832 | Broxuridine Plus Surgery in Treating Patients With Stage I or Stage II Prostate Cancer | completed | Phase 2 | 75 | National Cancer Institute (NCI)NIH | 1 | Jan 25, 2013 | clinicaltrials |
| NCT00028496 | Vaccine Therapy With or Without Sargramostim in Treating Patients With Advanced or Metastatic Cancer | completed | Phase 1 | 48 | National Cancer Institute (NCI)NIH | 1 | Jan 25, 2013 | clinicaltrials |
| NCT00096499 | SB-715992 in Treating Patients With Metastatic Prostate Cancer That Did Not Respond to Docetaxel or Paclitaxel | completed | Phase 2 | 40 | National Cancer Institute (NCI)NIH | 1 | Jan 25, 2013 | clinicaltrials |
| NCT00005039 | Vaccine Therapy in Treating Patients With Advanced Adenocarcinoma of the Prostate (Prostate Cancer) | terminated | Phase 2 | 86 | National Cancer Institute (NCI)NIH | 1 | Jan 24, 2013 | clinicaltrials |
| NCT00074022 | GTI-2040 and Docetaxel in Treating Patients With Recurrent, Metastatic, or Unresectable Locally Advanced Non-Small Cell Lung Cancer, Prostate Cancer, or Other Solid Tumors | completed | Phase 1 / Phase 2 | 48 | National Cancer Institute (NCI)NIH | 1 | Jan 24, 2013 | clinicaltrials |
| NCT00109811 | Vaccine Therapy in Treating Patients With Recurrent Prostate Cancer | completed | Phase 2 | 32 | National Cancer Institute (NCI)NIH | 1 | Jan 23, 2013 | clinicaltrials |
| NCT00551122 | Gemcitabine, Paclitaxel, Ifosfamide, and Cisplatin in Treating Patients With Progressive or Relapsed Metastatic Germ Cell Tumors(GemTIP) | unknown | Phase 1 / Phase 2 | 23 | University of SouthamptonOTHER | 1 | Jan 23, 2013 | clinicaltrials |
Data updated 23 days agoSource updated Mar 20, 2013source: clinicaltrials